Reference Capital SA

Investment Focus

Inferred Thesis

Auto-generated from public data. Not the firm's stated position.

Reference Capital SA appears to focus on early to growth-stage investments across biotech, fintech, and energy sectors, with a typical check size of €1.5M to €3.0M. Recent portfolio activity suggests an interest in companies pursuing innovation in pharmaceuticals, digital financial services, and renewable energy technologies.

Generated 11 Oct 2026 from disclosed sectors, stages, and portfolio companies. Firms can update this by emailing [email protected].

How to Pitch Reference Capital SA

No Stated Policy
Reference Capital SA hasn't published an outreach policy. A short, specific cold email is the safest default.

Portfolio Highlights

T3 Pharmaceuticals - Biopharma innovation, Monzo - Digital banking, GlassPoint - Solar energy

Focus and check size from the firm's website. Website reachable as of Aug 2026.

Ready to Reach Reference Capital SA?

A fit check scores your pitch against their thesis, stage and ticket. An email draft uses their real deals and thesis, not a template.